ABSTRACT

Background: The economics of rotavirus gastroenteritis in infants <5 years old is well-known within healthcare. The financial consequences for families, employers and authorities are not so well explored. The present study evaluates how vaccine prevention changes money flows among those involved in the management of disease, and its consequences.

Methods: A Social Accounting Matrix (SAM) framework has been developed reflecting the distribution of income and spending at equilibrium affected by rotavirus disease among all those concerned for 1 year. The data came from official sources and published literature. A comparison of the financial equilibrium between with and without a national rotavirus immunization program has been conducted, along with sensitivity analysis for the results.

Results: The total financial cost difference at equilibrium between presence and absence of rotavirus vaccination was +€26.758 million over one year as a net economic surplus. The payment of vaccination (€19.194 million) by the government was offset by the increase in tax revenue (€14.561 million) and by the lower spending in treatment care (€7.998 million).

Conclusion: Studying the financial flows between different transacting agents can demonstrate the financial burden of a disease and the benefits of its prevention on agents’ income and spending.

摘要

背景：轮状病毒性肠胃炎在5岁以下的婴儿中的经济学在医疗保健领域是众所周知的。对于家庭，雇主和当局的财务后果还没有得到很好的探讨。本研究评估了预防疫苗如何改变涉及疾病管理的人员之间的资金流动及其后果。

方法：建立了社会会计矩阵（SAM）框架，反映了轮状病毒疾病影响的所有相关人群在1年内收入和支出的均衡分配。数据来自官方资料和公开文献。比较了有和没有国家轮状病毒免疫计划之间的财务平衡，并对结果进行了敏感性分析。

结果：存在和不存在轮状病毒疫苗之间，处于平衡状态的总财务成本差额为一年净经济盈余+2675.8万欧元。政府的疫苗接种费用（1919.4万欧元）被税收收入的增加（1456.1万欧元）和治疗护理支出的减少（799.8万欧元）所抵消。

结论：研究不同交易媒介之间的财务往来可以证明疾病的经济负担及其预防对媒介收入和支出的好处。